Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Vaccine against COVID Sputnik V granted full permanent approval in Russia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the Russian Sputnik V vaccine against coronavirus has been granted full permanent...

SHINE Europe to build Advanced Medical Isotopes Facility in the Netherlands

A leader in nuclear technology obtains funding to produce medical isotopes in Europe and to help meet growing demands to provide diagnostic imaging for...

Russia and China are working on mutual recognition of COVID-19 vaccines

Earlier, the Russian Ministry of Economic Development announced that Russia had made agreements with six Chinese manufacturers for the production of Russian coronavirus vaccines...

Nuvaxovid is the first protein-based COVID-19 vaccine authorized in UK

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Medicines and Healthcare products...

New investments in the innovative biotechnology company “Target Medicals”

RDIF, AstraZeneca and Unicorn Capital Partners invest in Target Medicals, developing aldosterone synthase inhibitor for the treatment of resistant arterial hypertension. The Russian Direct Investment...

Rosselkhoznadzor removed the veterinary drug “Telazol 100 mg” from the list of prohibited

Rosselkhoznadzor announced that a veterinary drug Telazol 100 mg has been allowed to be imported into Russia. The decision comes after Rosselkhoznadzor has confirmed the...
spot_img

Expert Articles

spot_img